Back to DANSKE BANK A/S DANSKE BANK A/S

CNSPCNSP
4 quarters

Position history for DANSKE BANK A/SDANSKE BANK A/S's holdings in CNS PHARMACEUTICALS INC

Yes. Danske Bank holds 1 shares of CNSP (CNS Pharmaceuticals), worth $5, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Danske Bank has held CNSP since Q3 2025, across 4 quarterly 13F filings.

Current Value

$5

Current Shares

1

Total Value Change

-$4

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
1
0.0%
$50.0%$4.78
0
2026-Q1
Unchanged
1
0.0%
$20.0%$3.04
0
2025-Q4
Unchanged
1
0.0%
$50.0%$5.46
0
2025-Q3
New
1
-
$90.0%$8.89
17

Other major holders of CNSP: UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD FIDUCIARY TRUST CO, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used